Anrs, Emerging Infectious Diseases
Clinical trials sponsored by Anrs, Emerging Infectious Diseases, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Could a drug cocktail slash deaths from TB of the brain? Results expected Sep 2026 (estimated)
- Can a pill speed up monkeypox recovery? major trial underway Results expected Sep 2026 (estimated)
- Exercise program aims to keep HIV patients over 50 on their feet Results expected Oct 2026 (estimated)
- New nasal spray COVID-19 booster could replace needles Results expected Oct 2026 (estimated)
- New vaccine booster aims to shield against many coronaviruses Results expected Oct 2026 (estimated)
-
New vaccine booster aims to shield against many coronaviruses
Vaccine OngoingThis study tests a new booster vaccine called CD40.Pan.CoV in 48 healthy adults in France. The goal is to see if it is safe and can boost the body's defenses against multiple coronavirus variants. Participants receive one injection and are monitored for side effects and immune re…
Phase 1/2 • Sponsor: ANRS, Emerging Infectious Diseases • Aim: Vaccine
Last updated Jun 27, 2026 12:29 UTC
-
Can a pill speed up monkeypox recovery? major trial underway
Disease control OngoingThis study tests whether the antiviral drug tecovirimat can help people with monkeypox heal faster. About 480 adults and teens (14+) with active lesions will receive either tecovirimat or a placebo, alongside standard care. The main goal is to see how quickly skin and mouth sores…
Phase 3 • Sponsor: ANRS, Emerging Infectious Diseases • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
New hope for kids with hepatitis c: drug combo trial launches in cambodia
Disease control OngoingThis study is testing a combination of two antiviral drugs, sofosbuvir and daclatasvir, in children aged 6 and older with active hepatitis C in Cambodia. The goal is to see if the treatment can clear the virus from the blood 12 weeks after finishing the 12-week course. The trial …
Sponsor: ANRS, Emerging Infectious Diseases • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
French cities launch community push to wipe out hepatitis c in drug users
Disease control OngoingThis study aims to eliminate hepatitis C among people who use drugs in Paris, Marseille, Lyon, and Fort-de-France. Researchers will screen participants, provide immediate treatment, and use a peer-referral system to reach more people. The goal is to see if this community-based ap…
Sponsor: ANRS, Emerging Infectious Diseases • Aim: Disease control
Last updated Jun 26, 2026 14:26 UTC
-
Exercise program aims to keep HIV patients over 50 on their feet
Symptom relief OngoingThis study tests whether a 48-week exercise program can improve physical function and reduce disability in HIV-positive adults over 50 in Côte d'Ivoire. 180 participants will be split into three groups: supervised group exercise, home-based exercise with phone support, or health …
Sponsor: ANRS, Emerging Infectious Diseases • Aim: Symptom relief
Last updated Jun 27, 2026 07:51 UTC